Home UVA, Virginia Tech, VCU partnering in launch of new Virginia Research Triangle
Local, Virginia

UVA, Virginia Tech, VCU partnering in launch of new Virginia Research Triangle

Chris Graham
virginia politics
(© josephsjacobs – stock.adobe.com)

The University of Virginia, Virginia Tech and VCU are partnering with the Commonwealth to launch a biotechnology, life sciences and pharmaceutical manufacturing network that is being touted as a future Virginia Research Triangle.

The budget from the Youngkin administration that will be formally sent to the Virginia General Assembly next week will include a total of $90 million in one-time funds to the University of Virginia’s Manning Institute for Biotechnology, Virginia Tech’s Fralin Biomedical Research Institute at VTC, and the Virginia Commonwealth University’s Medicines for All Institute.

The institutions will partner with the Virginia Innovation Partnership Authority to collaborate on commercialization and startup support.

“Today’s investment announcement lays the groundwork for remarkable startup innovation and commercialization that interconnects Charlottesville, the Greater Richmond Area, Roanoke and the New River Valley,” Gov. Glenn Youngkin said in a statement in a news release from his office sent to media outlets on Monday.

“Through this state commitment and private philanthropy, we are building Virginia’s research triangle and network, supporting our higher education institutions’ research endeavors, and expanding Virginia’s university research capacity that will enhance life-saving research development for generations to come. My administration is committed to building Virginia’s research engine for the future and creating high-paying jobs in the process,” Youngkin said.

The Virginia Innovation Partnership Authority will convene the three institutions to sign a memorandum of understanding with the Authority and each other. Once the MOU is signed by the three institutions and by VIPA, $50 million will be available for UVA’s Manning Institute for Biotechnology, $27 million will be available for Virginia Tech’s Fralin Biomedical Research Institute at VTC, and $13 million will be available for VCU’s Medicines for All Institute.

“Innovation is at the heart of a thriving economy and the Commonwealth of Virginia. Today’s landmark investment announced by Gov. Youngkin will help accelerate university collaboration and elevate Virginia’s leadership in the critical biotech, life sciences, and pharmaceutical manufacturing health sectors,” said Joseph Benevento, president of the Virginia Innovation Partnership Authority.

“We are exceptionally grateful for the governor’s announcement today of the Commonwealth’s additional funding for the UVA Paul and Diane Manning Institute of Biotechnology,” said Dr. K. Craig Kent, CEO of UVA Health and executive vice president of health affairs for University of Virginia. “We look forward to continued collaboration with our other university research colleagues and the full spectrum of bioscience partners across Virginia.”

“The Commonwealth will greatly benefit from this major collaborative initiative from Gov. Youngkin to advance biomedical research, innovation and translation at and between the states major academic health centers. This investment will not only advance the ongoing biomedical and health sciences research at the states three largest academic medical centers but will facilitate increased collaboration and innovation between them,” said Dr. Mike Friedlander, executive director of Virginia Tech’s Fralin Biomedical Research Institute at VTC and Virginia Tech vice president of health sciences and technology.

“For the last decade, VCU’s Medicine for All Institute has led the world in developing innovations to making medicines by lowering costs, strengthening supply resilience, and increasing quality. As we look towards the next decade of the advanced pharmaceutical manufacturing industry in Virginia, Medicine for All is excited to be a partner in growing the capabilities and job opportunities this industry can bring to the Commonwealth. Gov. Youngkin’s continued investment and support is helping make this a reality and we are grateful to be a part of this important initiative,” said Dr. Frank Gupton, the co-founder of Phlow and CEO at Medicines for All.

 

Support AFP

Newsletter

Featured Video

 




Chris Graham

Chris Graham

Chris Graham is the founder and editor of Augusta Free Press. A 1994 alum of the University of Virginia, Chris is the author and co-author of seven books, including Poverty of Imagination, a memoir published in 2019. For his commentaries on news, sports and politics, go to his YouTube page, TikTok, BlueSky, or subscribe to his Street Knowledge podcast. Email Chris at [email protected]. Support AFP by signing up for our newsletter and/or powering our work with a one-time or monthly contribution.

Latest News

police arrest night crime accident
Virginia

Amherst County: Authorities make arrest connected to cockfighting investigation

staunton
Local

Staunton still seems to be flirting with the idea of a data center, for some reason

You know how Staunton city leaders have been insisting that they don’t want a data center in the Staunton Crossing development located at the nexus of Interstate 64 and Interstate 81?

open house real estate sign listing agent
Virginia

Virginia housing market continuing to cool, which is good news for buyers

The housing market in Virginia, mirroring a national trend, is continuing to cool, with the Virginia Association of REALTORS® reporting a 13.8 percent drop in home sales in October compared to a year ago, and pending sales down 18.9 percent.

James Franklin Virginia Tech
Sports

‘Big Game James’: Virginia Tech blows early 14-0 lead, falls at #7 Miami, 28-20

uva football beau pribula
Football

UVA Football: Elliott, ‘Hoos finally get things right, just, unfortunately, too late

school bus arm
Local

Waynesboro School Board set to name next school superintendent on Monday

da'shawn martin td
Football

UVA Football: How did the ‘Hoos give up 581 yards and still dominate UNC?